Empire Genomics Welcomes Andre Lubarsky as US Sales Director

July 20th, Buffalo, NY – Empire Genomics, a company that develops high-quality molecular probes for fluorescent and chromogenic in situ hybridization testing, has selected Andre Lubarsky to initiate the new North American business development strategy as Director of Sales. Andre is a seasoned sales director, most recently with System Biosciences, Inc., who will now be leveraging his experience to develop and execute key growth sales strategies in the United States and North America.

Andre has over seventeen years of experience as a sales director in the imaging/microscopy, cytogenetics, oncogenetics, and gene editing markets. “Andre is a proven sales executive and manager with deep experience and relationships in the genomics community,” said Anthony Scarpello, Chief Executive Officer at Empire Genomics. “His enthusiasm for building and leading commercial teams will significantly bolster our management team as we work to achieve our goals for 2022 and the future.”

Andre’s primary focus will be on boosting brand awareness and sales by expanding Empire Genomics’ customer base in North America. “My goal is to understand their business needs and objectives while building and maintaining strong, long-lasting customer relationships,” said Andre Lubarsky. He will also manage all efforts by the Empire Genomics sales team, creating and communicating sales goals and ways to achieve those goals, and continually find ways to motivate team members to boost morale and retention. He will work collaboratively with the sales and marketing teams to foster a culture of continuous process improvement while driving the successful implementation and adoption of the sales and marketing automation platforms.

Andre joins Empire Genomics from System Biosciences, Inc., in Palo Alto, California, and holds a bachelor’s degree in Biology and Organic Chemistry from University of California, San Diego.